Drugs / Alpha bisabolol
last change May 2021 re-read 3 minutes ago

Alpha bisabolol

Small molecule

Developed for
tinea unguium
Investigated by
Universidade do Vale do Sapucai

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT05022108 Apr → Aug 2020 — Universidade do Vale do Sapucai Completed No outcome recorded
Comparator or background therapy1 trial
Phase 1 NCT04940520 Comparator Jun → Nov 2020 tinea unguium Universidade do Vale do Sapucai Completed No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Alpha-bisabolol “Alpha-bisabolol, extracted from Candeia, has several applications in the treatment of illnesses, however, there are no studies on the therapeutic potential for antihistamine.” NCT05022108 ↗
2

NCT05022108 ↗

NCT04940520 ↗

Known as Bisabola-1,12-dien-8-ol ChEMBL registry synonym — accepted as the source's own label CHEMBL1096927 ↗
Known as Bisabolol ChEMBL registry synonym — accepted as the source's own label CHEMBL1096927 ↗
Known as Bisabolol, (-)-.alpha. ChEMBL registry synonym — accepted as the source's own label CHEMBL1096927 ↗
Known as Camilol ChEMBL registry synonym — accepted as the source's own label CHEMBL1096927 ↗
Known as Dragosantol ChEMBL registry synonym — accepted as the source's own label CHEMBL1096927 ↗
Known as Hydagen b ChEMBL registry synonym — accepted as the source's own label CHEMBL1096927 ↗
Known as Racemic alfa-bisabolol ChEMBL registry synonym — accepted as the source's own label CHEMBL1096927 ↗
Modality Small molecule — CHEMBL1096927 ↗
Route Topical “Using alpha bisabolol gel with a concentration of 0.5%, 2,5% or 5% to treat sensitized area with histamine.” NCT05022108 ↗